. Quantitative analysis of MOR phosphorylation in vivo. (A) MOR +/+ mice were injected with saline (n = 3), 30 mg/kg morphine (n = 3), or 30 µg/kg etonitazene (n = 3). (B) MOR +/+ (n = 3) and MOR -/-(n = 3) mice were injected with 30 µg/kg etonitazene. (C) MOR +/+ (n = 3) and MOR S375A/S375A (n = 3) mice were injected with 0.3 mg/kg fentanyl. After 30 min, brains were dissected, and homogenates were prepared from the entire brain after removal of the cerebellum. MORs were immunoprecipitated with UMB-3 and immunoblotted with guinea pig anti-pT370, anti-pS375, or anti-pT379 antibody. Blots were stripped and re-probed with phosphorylation-independent guinea pig anti-MOR antibody to confirm equal loading of the gel. MOR phosphorylation was quantified and expressed as percentage of maximal phosphorylation in wild-type mice. Data are shown as mean ± standard error of the mean (SEM; n = 3 per group and genotype). MOR, µ-opioid receptor.
Figure S2. Mass spectrometry (MS) analysis of immunoprecipitated MOP receptor from saline-or etonitazene-treated MOR
+/+ mice brain. After SDS-PAGE, trypsin digestion, and nanoLC-MS/MS decision tree-driven CID/ETD analyses, Mascot database searches, including putative phosphorylation modification, identified the MOP receptor sequence with 10-33% coverage, depending on the sample. Although limited, this coverage enabled us to unambiguously identify unphosphorylated and phosphorylated forms of T370 and S375 containing peptides. Phosphorylated and unphosphorylated peptides containing T370 and S375 were quantified using the MFPaQ software. Representative spectra are shown. -/-(n = 4) mice were injected with 0.3 mg/kg fentanyl. After 30 min, brains were dissected, and homogenates were prepared from the entire brain after removal of the cerebellum. MORs were immunoprecipitated with UMB-3 and immunoblotted with guinea pig anti-pT370 antibody (upper panel). Blots were stripped and re-probed with phosphorylationindependent guinea pig anti-MOR antibody to confirm equal loading of the gel (lower panel). (B) T370 phosphorylation was quantified and expressed as percentage of maximal phosphorylation in WT mice (n = 4 per genotype). Data are presented as the means ± SEM. GRK, G proteincoupled receptor kinase; MOR, µ-opioid receptor; WT, wild-type. -/-mice. During the preconditioning phase (Pre), time spent in each side of the CPP apparatus was assessed. Drug was randomly paired with one side during conditioning. During the post-conditioning phase, time spent in each side was assessed on days 1, 7, 14, 21, and 28 in the absence of cocaine or saline. Cocaine-evoked preference and extinction of cocaine CPP were similar in GRK3 -/-(n = 6) mice and WT mice (n = 6) (for genotype, F (1,10) = 0.18; p = 0.6839; for time, F (5,50) = 2.21; p = 0.0675), suggesting that deletion of GRK3 has no impact on dopamine receptor function. Data are shown as the difference in time spent in the drug-paired and saline-paired sides. CPP, conditioned place preference; GRK, G protein-coupled receptor kinase; WT, wild-type.
Supplemental Material and Methods

Drugs
Morphine hydrochloride and naloxone hydrochloride were obtained from Merck (Darmstadt, Germany), fentanyl citrate was purchased from Rotexmedica (Trittau, Germany), and etonitazene hydrochloride and cocaine hydrochloride were purchased from Sigma-Aldrich (Steinheim, Germany). Drugs were dissolved in physiological saline and injected subcutaneously in a volume of 10 ml/kg. SL327 was obtained from Tocris Bioscience (Bristol, UK) and dissolved in saline with 5% DMSO and 20% Cremophor.
Behavioral Tests
In all behavioral experiments, male knock-out mice and their WT littermates were between 12-16 weeks of age and 25-30 g. Acute anti-nociceptive responses were assessed using the hot-plate test (Ugo Basile, Comerio, Italy). Basal pain responses were determined at hot plate temperatures of 50°C, 52°C, 54°C, and 56°C on consecutive test days. During each test, latency to lick or flick hindpaws was measured from the time the mouse was placed on the hot-plate. To avoid tissue damage, mice were exposure to the hot-plate for no more than 30 s. The rewarding properties of opioids were measured using the conditioned place preference (CPP) test. All CPP experiments were conducted in a designated mouse testing room in which no other activities took place during the same time. Mice were tested in a 3-chambered box (TSE Systems, Bad Homburg, Germany). During the habituation phase, mice were allowed free access to all chambers for 30 min on 4 consecutive days. During a place preference test, the amount of time mice spent in each side (left or right) during a 10-min testing period was recorded. Only those mice with no significant place preference underwent subsequent conditioning. Mice were randomly divided into two groups: one group received drug in the morning and saline in the afternoon, the other group received saline in the morning and drug in the afternoon. Left and right sides were randomly assigned to be "drug-paired" and "saline-paired" sides. Immediately after subcutaneous injection of morphine (10 mg/kg), cocaine (10 mg/kg), fentanyl (0.5 mg/kg), or saline, mice were placed into the corresponding side. To assess the consequence of a chemical inhibition of the ERK-pathway on morphine-induced CPP, the MEK1/MEK2 inhibitor SL327 was injected intraperitoneally 1 h before each morphine administration. Morphine-and cocaine-injected mice remained in the chamber for 30 min, and fentanyl-injected mice remained in the chamber for 15 min. After four conditioning sessions, mice were allowed free access to all chambers for 10 min, and the time spent in each side was recorded. CPP was calculated as (time spent in the drug-paired side) -(time spent in the salinepaired side). The extinction of CPP was evaluated once a week for at least 4 weeks.
In vivo MOR Phosphorylation
Mice were anesthetized by isoflurane, killed by cervical dislocation, and brains were quickly dissected. The cerebellum, which is devoid of MORs, was removed. The remaining brain samples were immediately frozen in liquid nitrogen. In all experiments, entire brains except for the cerebellum were used. Samples were transferred to ice-cold detergent buffer (50 mM TrisHCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 10 mM NaF, 10 mM disodium pyrophosphate, 1%
Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS) containing protease and phosphatase inhibitors), homogenized, and centrifuged at 16,000 × g for 30 min at 4°C. The supernatant was then immunoprecipitated with the phosphorylation-independent rabbit monoclonal anti-MOR antibody (UMB-3) bound to protein A-agarose beads for 2 h at 4°C (1, 2).
Proteins were eluted from the beads with SDS-sample buffer for 20 min at 40°C. Samples were resolved on 8% SDS-polyacrylamide gels. After electroblotting, membranes were incubated with guinea pig polyclonal anti-pT370 (GPM370-1), anti-pS375 (GM375-2), or anti-pT379 (GPM379-2) antibodies. Blots were subsequently stripped and re-probed with phosphorylationindependent guinea pig polyclonal anti-MOR antibody (GP6) to confirm equal loading of the gels (1, 2). 
In vivo NanoLC-MS/MS Analysis
